R&D
Research & Development
Kolon Pharmaceuticals is dedicated to innovating and creating value through relentless research and development.
Significant enhancements in the speed and cost-efficiency of novel drug development
Increased success rates for candidate drugs
Pursuit of high-value global license out deals
Strategizing efficient clinical trials by testing and verifying various drug regimens and indications
Producing high-quality pre-clinical data grounded in rigorous scientific verification
Implementing reverse translational research for re-verification
KPC, World’s Top-Tier R&D Capabilities in Clinical Translational Research
Engaging in bidirectional studies to develop advanced treatment methodologies by integrating foundational scientific discoveries into practical clinical research
Dr. Kim contributed to the development of 12 groundbreaking anticancer drugs at the MD Anderson Cancer Center.
KPC offers clinical translational research services, amplifying the potential value of new drug candidates.
